Science
Mechanism of Action
Lidocaine operates by selectively inhibiting voltage-gated sodium ion channels located within neuronal membranes. This action effectively prevents depolarization and halts the generation and propagation of nerve impulses. Consequently, sensory neurons are prevented from transmitting pain signals to the brain, resulting in localized numbness and transient pain relief.
Research
Clinical Evidence
High confidence4%
Key findings
- 01 Topical 4% lidocaine gel provides significant anesthesia within 25-30 minutes, with optimal effects observed between 35-40 minutes, and is considered safe and effective for topical use in clinical settings without producing toxic plasma levels.
- 02 A topical system delivering 1.8% lidocaine demonstrated bioequivalence in drug delivery to a 5% lidocaine patch, indicating effective dermal penetration and comparable safety.
- 03 A cream combining 7% lidocaine and 7% tetracaine proved efficacious and safe for pain relief during facial soft tissue augmentation and fractional laser resurfacing procedures.
Transparency
Dusting Analysis
Lidocaine is a regulated active pharmaceutical ingredient (API) with specific concentration guidelines for its pharmacological effects. It is not an ingredient typically 'dusted' in cosmetics for marketing purposes, as its efficacy is directly tied to its therapeutic dosage and regulatory compliance.
The Formula
Formulation
Stability
Lidocaine exhibits maximum stability at room temperature within a pH range of approximately 3 to 6. Aqueous solutions of Lidocaine Hydrochloride are typically acidic (pH 4-5). Precipitation of Lidocaine Hydrochloride may occur at pH values exceeding 7, given its pKa of approximately 7.8. Increased reactivity is observed in the presence of metal ions such as Fe2+ and Cu2+.
Synergies
- Epinephrine (increases effectiveness and duration of local anesthesia)
Conflicts
- Phenytoin sodium
- Parabens (for individuals with allergic reactions to ester local anesthetics)
- Alkalinized lidocaine solutions (decreases epinephrine stability, requiring immediate preparation)
- Metal ions (e.g., Fe2+, Cu2+)
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not specifically assessed Lidocaine as a general cosmetic ingredient. However, the FDA warns against the use of over-the-counter (OTC) products containing more than 4% lidocaine on the skin, as higher concentrations significantly elevate the risk of systemic absorption and potential toxicity, which can manifest as serious adverse effects including irregular heartbeat, seizures, and breathing difficulties. Applying lidocaine over large skin areas, for prolonged periods, or to irritated/broken skin further increases this risk. The European Union Cosmetics Directive lists Lidocaine HCl as 'banned or found unsafe for use in cosmetics.' EWG Skin Deep rates Lidocaine HCl as 'Unacceptable' for EWG VERIFIED products due to 'Use Restrictions' and 'Violation of government restrictions'.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its efficacy as a local anesthetic, Lidocaine is not recommended for general cosmetic formulations due to significant safety concerns, FDA warnings regarding systemic toxicity at concentrations above 4% for OTC use, and its classification as 'banned or unsafe' for cosmetic use in the EU.
Related
Similar Ingredients
Finding similar ingredients…